±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 5985  |  »Ø¸´: 154
±¾Ìû²úÉú 1 ¸ö BM-EPI £¬µã»÷ÕâÀï½øÐв鿴
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

»ÆÍª

ľ³æ (ÖøÃûдÊÖ)


[×ÊÔ´] ÉúÎï²ÄÁϾ­µäBiomaterials for clinical applications ÒÑÓÐ1È˲ÎÓë

Biomaterials for clinical applicationsÊÇÉúÎï²ÄÁÏ·½ÃæµÄ¾­µäÖ®×÷£¬ÓõÃÉϵĸϽôÏÂÔØ°É£¬²»ÒªÁßϧºÃÆÀŶ£¬Ç×Ϊ·½±ã´ó¼Ò£¬ÏÖ°ÑĿ¼±à¼­ºÃ¡£
1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1 TheWorldwideBurden ofDisease . . . . . . . . . . . . . . . . 2
1.2 Global Population Aging and the Burden of Disease . . . . . . 8
1.3 The Global Economic Impact of Disease . . . . . . . . . . . . 10
1.4 TheRoleofNovelBiomaterials inAlleviatingDisease . . . . . 15
1.5 Practical Considerations for Modern Biomaterials . . . . . . . . 18
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2 Coronary Artery Disease . . . . . . . . . . . . . . . . . . . . . . . . 23
2.1 Historical Perspective on Coronary Artery Disease . . . . . . . 23
2.2 Pathology of Coronary Artery Disease . . . . . . . . . . . . . . 24
2.3 Biomaterials as Bioactive Stents . . . . . . . . . . . . . . . . . 33
2.4 Biomaterials as Degradable Stents . . . . . . . . . . . . . . . . 38
2.5 Biomaterials for Cardiac Regeneration . . . . . . . . . . . . . . 42
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3 Stroke . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.1 Pathology ofStroke . . . . . . . . . . . . . . . . . . . . . . . . 51
3.2 Biomaterials forBrain Imaging . . . . . . . . . . . . . . . . . 62
3.3 Biomaterials for Nerve Regeneration . . . . . . . . . . . . . . 68
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
4 Pneumonia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
4.1 Historical Perspective on Pneumonia . . . . . . . . . . . . . . 75
4.2 Pathology of Pneumonia . . . . . . . . . . . . . . . . . . . . . 76
4.3 Biomaterials asNovelAntibioticCarriers . . . . . . . . . . . . 85
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
5 COPD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
5.1 Historical Perspective on COPD . . . . . . . . . . . . . . . . . 99
5.2 Pathology ofCOPD . . . . . . . . . . . . . . . . . . . . . . . 100
5.3 Biomaterials for Lung Regeneration . . . . . . . . . . . . . . . 107
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
6 Diarrheal Diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
6.1 Pathology ofDiarrhea . . . . . . . . . . . . . . . . . . . . . . 122
6.2 Complexity and Cost of Current Diagnostic Methods . . . . . . 133
6.3 Biomaterials as Low-Cost Diagnostic Devices . . . . . . . . . . 136
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
7 HIV/AIDS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
7.1 Pathogenesis of HIV/AIDS . . . . . . . . . . . . . . . . . . . . 148
7.2 Biomaterials as Vaccine Adjuvants . . . . . . . . . . . . . . . . 156
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
8 Tuberculosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 167
8.1 Pathology of Tuberculosis . . . . . . . . . . . . . . . . . . . . 168
8.2 Biomaterials forSustainedDrugRelease . . . . . . . . . . . . 175
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 180
9 Lung Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183
9.1 Pathology of Lung Cancer . . . . . . . . . . . . . . . . . . . . 183
9.2 Biomaterials forPassiveTargetedDrugDelivery . . . . . . . . 190
9.3 Biomaterials forActiveTargetedDrugDelivery . . . . . . . . . 200
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 208
10 Traumatic Injuries . . . . . . . . . . . . . . . . . . . . . . . . . . . 213
10.1 Clinical Necessity for Wound Closure Technologies . . . . . . 214
10.2 Fibrin-Based Biomaterials for Wound Closure . . . . . . . . . . 220
10.3 Cyanoacrylate-Based Biomaterials as Tissue Glues . . . . . . . 225
10.4 CrosslinkedProtein-BasedBiomaterials asTissueGlues . . . . 232
10.5 Polyethylene Glycol (PEG)-Based Biomaterials
for Wound Closure . . . . . . . . . . . . . . . . . . . . . . . . 238
10.6 Emerging Biomaterials for Wound Closure . . . . . . . . . . . 245
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 249
11 Prematurity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 259
11.1 LungSurfactant andRespiratoryDistress inInfants . . . . . . . 259
11.2 Biomaterials as Synthetic Surfactants for the Lungs . . . . . . . 267
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 273
12 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 277
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 278
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 279

[ Last edited by »ÆÍª on 2012-10-28 at 08:47 ]
»Ø¸´´ËÂ¥

» ±¾Ìû¸½¼þ×ÊÔ´Áбí

  • »¶Ó­¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
    ±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com
  • ¸½¼þ 1 : Biomaterialsforclinicalapplications.pdf
  • 2012-10-27 19:04:12, 6.95 M

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

tinayp

ľ³æ (ÕýʽдÊÖ)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

ÔõôÏÂÔØ£¿
152Â¥2021-02-28 13:47:34
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 155 ¸ö»Ø´ð
¼òµ¥»Ø¸´
shent3Â¥
2012-10-28 22:01   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
2012-10-28 22:48   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
2012-10-29 10:22   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
2012-10-29 12:44   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
ÓÅÓö7Â¥
2012-10-30 13:14   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
guonick8Â¥
2012-10-30 21:55   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
xipha9Â¥
2012-10-31 15:09   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
imhnwam10Â¥
2012-10-31 17:06   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
chambinsg11Â¥
2012-10-31 17:49   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
wtiger12Â¥
2012-10-31 18:39   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
liuweische13Â¥
2012-10-31 23:18   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 270Çóµ÷¼Á +4 º£Ì¦»¨Éú±ý 2026-03-28 4/200 2026-04-03 12:15 by xingguangj
[¿¼ÑÐ] 335Çóµ÷¼Á +5 ÉòÇåÁ§ 2026-04-03 5/250 2026-04-03 12:03 by wxiongid
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +6 ´Þwj 2026-04-02 6/300 2026-04-03 10:19 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 286Çóµ÷¼Á +4 lim0922 2026-04-02 4/200 2026-04-03 09:46 by JourneyLucky
[¿¼ÑÐ] 312Çóµ÷¼Á +6 ССī123 2026-04-02 7/350 2026-04-03 07:32 by jsw79
[¿¼ÑÐ] ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£© +6 ÏàÐűػá¹ââÍòÕ 2026-03-31 7/350 2026-04-02 23:16 by JourneyLucky
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +8 ÀÁÑòÑòÇáÖÃÓñÍÎ 2026-04-02 8/400 2026-04-02 22:03 by liu823948201
[¿¼ÑÐ] 342Çóµ÷¼Á +16 Mary Keen 2026-03-28 17/850 2026-04-02 21:14 by 690616278
[¿¼ÑÐ] 22408µ÷¼Á +3 EEchoooo 2026-03-27 5/250 2026-04-02 20:19 by EEchoooo
[¿¼ÑÐ] Çóµ÷¼Á 302·Ö³õÊÔ 0854 +5 Áæ¿ÉÀÖ 2026-04-02 5/250 2026-04-02 17:53 by ±ÊÂä½õÖÝ
[¿¼ÑÐ] 310Çóµ÷¼Á +17 ÕùÈ¡¾Åµã˯ 2026-03-30 17/850 2026-04-02 16:40 by guanxin1001
[¿¼ÑÐ] 348»·¾³¹¤³Ìµ÷¼Á +3 ÎâÑå׿24k 2026-04-01 3/150 2026-04-02 09:14 by nanaliuyun
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì£¬×Ü·Ö358 +4 cs0106 2026-04-01 4/200 2026-04-02 07:42 by ÉÐË®¸óÖ÷
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤£¨0856£©304ÇóBÇøµ÷¼Á +8 Çñgl 2026-03-30 16/800 2026-04-01 17:58 by Çñgl
[¿¼ÑÐ] 0703Çóµ÷¼Á +4 zizimo 2026-03-31 4/200 2026-04-01 16:04 by yanflower7133
[¿¼ÑÐ] 262Çóµ÷¼Á +9 ÀøÖ¾Ò»¶¨·¢ÎÄÕ 2026-03-31 10/500 2026-04-01 12:22 by sunshine0013
[¿¼ÑÐ] 370Çóµ÷¼Á +3 080700µ÷¼Á 2026-03-30 3/150 2026-03-31 01:09 by A_Zhe
[¿¼ÑÐ] ¸£½¨Àí¹¤´óѧ²ÄÁÏѧԺÏȽøºÏ½ðÍŶÓÕÐÊÕ¿¼Ñе÷¼ÁѧÉú +3 ´ó»ª½ðÉ̶¼ 2026-03-30 4/200 2026-03-31 01:04 by ·½Ó¢¿¡602
[¿¼ÑÐ] µ÷¼Á +4 GK72 2026-03-30 4/200 2026-03-30 20:32 by dick_runner
[¿¼ÑÐ] 332Çó92µ÷¼Á +8 ½¶½¶123 2026-03-28 8/400 2026-03-29 10:46 by ÖÜè÷µ¤
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û